Objectives Inflammation may be implicated in the haemodynamic deterioration and in the development of complications in patients with cirrhosis. High-sensitivity C-reactive protein (hsCRP) is a marker of low-grade inflammation, and predicts outcomes in patients at risk of ischaemic heart disease. Proinflammatory cytokines reflect immune activation and have been found to be elevated in cirrhosis. We investigated a possible association between markers of inflammation and splanchnic and systemic haemodynamics, complications and survival in patients with cirrhosis.
Introduction
Portal hypertension with development of a hyperdynamic circulation is closely linked to complications and outcomes in cirrhosis [1] . Proinflammatory cytokines have been found to be elevated in some patients with cirrhosis [2] [3] [4] , and are related to impairment of the circulation [5] . A proinflammatory state has been proposed to induce certain complications [6] [7] [8] [9] [10] [11] [12] . Furthermore, altered immune function may lead to greater susceptibility to infections [13] , which are important predictors of the survival [14] .
High-sensitivity C-reactive protein (hsCRP) is an assay for measuring C-reactive protein (CRP) concentrations below the cut-off level used for diagnosing inflammation and infection. hsCRP measurements have been shown to predict cardiovascular incidents in apparently healthy persons [15] , and it is considered as a marker of low-grade inflammation [16] .
Tumour necrosis factor-a (TNF-a), monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) and interleukin-8 (IL-8) are known as markers of immune activity linked to specific parts of the immune response and have previously been found to be variably elevated in chronic liver disease [2] [3] [4] 17] . Vascular endothelial growth factor (VEGF) is a marker of neovascularization and fibrosis, suggested to be implicated in specific complications of cirrhosis including hepatopulmonary syndrome (HPS) [18] .
In the present study, we hypothesized a predictive relationship between investigated markers of immune function, including hsCRP, and proinflammatory cytokines and haemodynamic status, complications and survival in stable cirrhotic patients without signs of infection.
Methods

Study population
Forty-five patients with cirrhosis and 12 healthy, agematched controls were included in the study.
All patients were recruited from a series of consecutive referrals from outpatient clinics for liver vein catherization in a previous study on pulmonary dysfunction in patients with cirrhosis [19] .
The diagnosis of cirrhosis was made solely on the basis of histology or by a combination of clinical, endoscopic and ultrasonographic findings. Diuretics were stopped 24 h before liver vein catherization.
All patients had an underlying aetiology of alcohol intake (a daily intake of more than 50 g of alcohol a day for more than 5 years), or in three patients, a combination of alcohol and other aetiologies (two patients with autoimmune hepatitis and one with chronic hepatitis B infection).
All patients had abstained from alcohol consumption for at least 2 months before entry into the study.
No patients had symptomatic infections or clinical signs of infection on the day of investigation. No patients had taken antibiotics for a period of 3 weeks before sample collection. For the purpose of the present study, complications were divided into (a) presence of ascites, (b) presence of oesophageal varices, (c) presence of HPS and (d) presence of renal dysfunction.
Study protocol
A liver vein catherization including measurement of the hepatic venous pressure gradient (HVPG) was performed in all patients as previously described [20, 21] . Splanchnic and systemic haemodynamic investigations included determination of hepatic blood flow using the indocyanine green constant infusion technique [21] . Cardiac output was determined using the indicator dilution technique with 123 I-labelled albumin as previously described [20] . Plasma volume was determined as the amount of injected tracer divided by the plasma concentration 10 min after injection. Galactose elimination capacity was assessed as previously described [21] .
The presence of HPS was determined by contrastenhanced echocardiography and 99m Tc-macroaggregated albumin lung perfusion scintigraphy [19] . Arterial blood gas variables, and spirometric variables and lung diffusion capacity data were recorded.
The presence of ascites was determined by ultrasonographic examination.
The presence of oesophageal varices was determined by a review of patient records at the time of inclusion.
The estimated glomerular filtration rate was calculated using the simplified Modification of Diet in Renal Disease formula [22] .
The concentrations of the cytokines TNF-a, IL-6, IL-8, MCP-1 and VEGF were measured using the coloured bead multiplex technology (Luminex Corporation, Austin, Texas, USA).
hsCRP was measured by an enzyme-linked immunosorbent assay (DRG Instruments GmbH, Marburg, Germany) according to the manufacturer's instructions.
Patients were followed in an outpatient clinic at 3-6-month intervals from inclusion until death or review of data. A national register based on the patient's social security number confirmed survival data. 
Results
The demographic, biochemical, clinical and haemodynamic characteristics of the 45 patients and 12 agematched controls are shown in Tables 1 and 2 .
High-sensitivity C-reactive protein hsCRP levels (range: 0.54-20.6 mg/l) were within the normal range in 36 patients (80%) and mildly elevated in nine patients (20%). hsCRP was within the normal range in all controls (range: 0.44-9.72 mg/l).
As a group, patients had significantly higher hsCRP levels compared with controls (P = 0.012), with the highest levels in patients with more advanced liver disease; see Table 3 and Fig. 1 . Patients with Child-Pugh score C had significantly higher hsCRP levels than Child-Pugh B patients and controls. However, the difference between Child-Pugh C and A patients (P = 0.056), Child-Pugh A patients and controls (P = 0.3202) and Child-Pugh B and controls (P = 0.3202) did not reach statistical significance.
hsCRP levels correlated to markers of liver function: serum bilirubin (r = 0.35, P = 0.03), serum albumin (r = -0.39, P = 0.013) and serum sodium (r = -0.38, P = 0.01).
hsCRP levels also correlated with HVPG (r = 0.48 and P < 0.001) as shown in Fig. 2 .
hsCRP did not correlate with the systemic haemodynamic variables, including arterial blood pressure, cardiac output, central blood volume, systemic vascular resistance or plasma volume.
Furthermore, hsCRP did not correlate with pulmonary variables, and no significant differences in the hsCRP levels were observed with respect to the presence (five patients) or absence (40 patients) of HPS.
Patients with ascites had higher levels of hsCRP than patients without ascites (7.4 vs. 5.2 mg/l, P < 0.05). Patients with moderate or large oesophageal varices had modestly increased hsCRP levels (6.7 vs. 5.1 mg/l), although this did not reach statistical significance in either group (P = 0.08, 0.18, respectively).
No correlation with estimated glomerular filtration rate was observed.
Cytokines
The concentrations of MCP-1 were significantly lower in patients than in controls (236 vs. 461 pg/ml, P < 0.001). The MCP-1 concentration was related to Child-Pugh stage [Child-Pugh stage A significantly different from stage C (P < 0.01) and B (P < 0.05), as shown in Table 3 ].
IL-8 was significantly higher in patients than in controls (P < 0.05), and although the concentrations of TNF-a and IL-6 tended to be higher in patients than in controls, these differences did not reach statistical significance, as shown in Table 3 .
VEGF concentrations did not differ significantly between patients and controls.
No significant relationship between any of the cytokines and splanchnic or systemic haemodynamics could be demonstrated in the present study.
With regard to complications, MCP-1 was significantly lower in patients with ascites (P = 0.028); patients with ascites did not differ with respect to other cytokines.
With regard to renal function and the presence of varices, we found no association with any of the measured cytokines.
Regarding pulmonary variables, the concentrations of MCP-1 correlated with D L CO (r = 0.367, P < 0.05), and in patients with HPS, we found significantly increased levels of VEGF (P < 0.05).
Survival
At follow-up, patients had been observed for a median of 3.6 years (range: 43-84 months) or until death. During the follow-up period, 23 out of 45 patients (51%) died.
We analysed the impact of hsCRP on survival using univariate regression analysis and demonstrated a significant impact of hsCRP on survival. Analysing the impact of known prognostic scores, we found the Model for EndStage Liver Disease score, but not the Child-Pugh score, to predict survival in the present study (Table 4 ). In multivariate analysis including hsCRP and the MELD score, hsCRP retained independent prognostic significance (P = 0.046).
The patients were divided into two groups by the median hsCRP levels. This resulted in a highly significant difference in survival favouring patients with hsCRP at or below the median level of 5.3 mg/l (log rank test, P = 0.001), as shown by the Kaplan-Meier plot in Fig. 3 .
On limiting the analysis to short-term outcomes, defined as death within 3 months of follow-up, the MELD score contained prognostic information on survival (P = 0.042); however, hsCRP did not (P = 0.101).
By analysing the receiver operating curves of hsCRP and the MELD score, we determined the area under the curve of hsCRP, a measure of diagnostic accuracy, to be 0.72; the corresponding number for the MELD score was 0.79. Calculating the combined score for hsCRP and the MELD score obtained by the lineary predictor of logistic regression analysis, we found a similar area under the curve (combined score 0.79), as shown in Fig. 4 .
We found an hsCRP level of 5.4 mg/l to be the optimal cut-off point for hsCRP, with a sensitivity of 0.71 and a specificity of 0.76 for the prediction of death in the follow-up period.
We observed no significant impact of the levels of the five measured cytokines on survival.
Discussion
Inflammation is thought to contribute to the haemodynamic alterations of cirrhosis [23] and may also contribute to specific complications, such as alcoholic hepatitis [12] , hepatorenal syndrome [8] , hepatic encephalopathy [24] and variceal bleeding [6] . The systemic inflammatory response syndrome has been shown to be associated with an adverse outcome in patients with cirrhosis [25, 26] .
The present study is the first to describe hsCRP levels in stable patients without clinical signs of infection, their relations to haemodynamic parameters and complications as well as their prognostic value. We found that hsCRP concentrations alone were associated not only with disease severity but also with haemodynamic alterations and predicted survival.
The present findings support a possible impact of chronic low-grade inflammation on progression of disease and chances of survival.
The passage of viable bacteria and bacterial components of gut origin to mesenterial lymph nodes, as well as to the systemic circulation, has been demonstrated to occur more frequently in patients with advanced cirrhosis [27] and may be a consequence of a number of factors including increased intestinal permeability [28] , impaired reticuloendothelial function [29] and decreased synthesis of complement factors [30] .
This process, termed bacterial translocation, may cause overt infection as in spontaneous bacterial peritonitis, and has been hypothesized to have more subtle but no less serious consequences. Antigen stimulation has been proposed to contribute to the hyperdynamic circulation by promoting the release of vasodilatory substances including nitrogen oxide [23, 31, 32] . Another proposed effect of chronic antigen stimulation is disturbed immune function [33] , which may promote susceptibility to infections [13] , complications and possibly increasing bacterial translocation in a downward spiral of complications.
We found low levels of MCP-1, a signalling molecule involved in monocyte/macrophage chemotaxis that is related to disease severity and to pulmonary complications, and high levels of IL-8, involved in neutrophil chemotaxis in the present study. These findings may be a reflection of a dysregulated immune response, which we speculate may be influenced by chronic antigen stimulation.
In patients with HPS, we found high systemic levels of VEGF, a finding that agrees with recent results in experimental HPS, supporting a direct role for VEGF signalling in angiogenesis and experimental HPS [18] .
We did not find any significant association between Child-Pugh stage and levels of TNF-a, IL-6 or VEGF. Although cytokines have previously been found to be elevated in some patients with cirrhosis [2, 3] , others have found these to be only slightly elevated [34] . The lower levels of TNF-a and IL-6 seen in the present study may indicate that these cytokines are more variable than the stable marker hsCRP or represent a different part of immune activation present in our patient group. A recent study, however, investigated cytokines in stable patients with cirrhosis including TNF-a, IL-6 and IL-8, and found only IL-8 to be higher in patients compared with controls, mirroring our findings [35] .
The strengths of the present study are a complete followup in a well-characterized study population including haemodynamic and respiratory parameters, as well as the use of an age-matched control group.
The weaknesses are the cross-sectional and retrospective nature of the study, which does not permit us to discern causality between, on the one hand, the process of inflammation and, on the other, markers of liver pathophysiology. CRP is an established marker of infection, and although all patients included in the present study were stable outpatients without clinical signs of infection and the majority of patients had CRP levels within the normal range, we cannot rule out that an undetected infection may have caused mild CRP elevation in some patients. Mild undetected clinical infections, however, cannot explain the observed difference in survival as the vast majority of deaths occurred months or years after hsCRP measurement.
In a recent paper, CRP had the highest capability in diagnosing infections in hospitalized cirrhotic patients compared with several other acute-phase reactants. In the same study of patients with cirrhosis admitted to hospital without overt infection, elevated CRP levels predicted the short-term risk of infections [36] . We do not have data on infections during the follow-up period in our study, although the relationship between markers of inflammation, infection, other complications and cause-specific mortality should be explored further in larger, prospective studies.
We found a relationship between hsCRP and the HVPG, an important and clinically relevant measure of haemodynamic alterations in cirrhosis. A previous study has demonstrated that treatment with antibiotics improved hepatic haemodynamics in patients with cirrhosis and was accompanied by reduced levels of endotoxins [32] , which are potent stimulators of the inflammatory process. However, the potential causes that underlie the relationship demonstrated in this study remain to be determined.
The finding that hsCRP, even within normal ranges, may provide prognostic information in stable patients with cirrhosis without signs of infection is a novel one and a finding that may have clinical implications, even though hsCRP did not predict short-time survival in the present study. hsCRP is a readily available and low-cost assay, and if its potential is demonstrated in larger trials, it may be incorporated into known prognostic scores, leading to improved organ allocation.
In conclusion, hsCRP levels predict survival and are associated with haemodynamic alterations in patients with alcoholic cirrhosis.
